Global Genomics AB Signs Collaboration Agreement With Rheoscience A/S
10/19/2005 5:11:29 PM
Global Genomics(SM) AB (Stockholm, Sweden) announced today that Rheoscience A/S (Roedovre, Denmark) has entered into an agreement for the use tangerine(R) gene expression profiling to study targets in metabolic diseases. Ulf Boberg, CEO at Global Genomics stated, "This agreement is yet another confirmation of that researchers are demanding gene expression technologies that provide higher quality information. We are very excited about expanding our customer base and broadening customer awareness."
comments powered by